152 related articles for article (PubMed ID: 36921746)
21. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
[TBL] [Abstract][Full Text] [Related]
22. Complementarity of mDSC, DMA, and DRS Techniques in the Study of
Thayumanasundaram S; Venkatesan TR; Ousset A; Van Hollebeke K; Aerts L; Wübbenhorst M; Van den Mooter G
Mol Pharm; 2022 Jul; 19(7):2299-2315. PubMed ID: 35674392
[TBL] [Abstract][Full Text] [Related]
23. Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form.
Xiong X; Xu K; Li S; Tang P; Xiao Y; Li H
Drug Dev Ind Pharm; 2017 Feb; 43(2):283-292. PubMed ID: 27648489
[TBL] [Abstract][Full Text] [Related]
24. Hot Melt Extrusion and Spray Drying of Co-amorphous Indomethacin-Arginine With Polymers.
Lenz E; Löbmann K; Rades T; Knop K; Kleinebudde P
J Pharm Sci; 2017 Jan; 106(1):302-312. PubMed ID: 27817830
[TBL] [Abstract][Full Text] [Related]
25. Amino acids as stabilizers for spray-dried simvastatin powder for inhalation.
Lu W; Rades T; Rantanen J; Chan HK; Yang M
Int J Pharm; 2019 Dec; 572():118724. PubMed ID: 31678523
[TBL] [Abstract][Full Text] [Related]
26. The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers.
Semjonov K; Kogermann K; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
Eur J Pharm Sci; 2017 Jan; 97():237-246. PubMed ID: 27890595
[TBL] [Abstract][Full Text] [Related]
27. The Role of Glass Transition Temperatures in Coamorphous Drug-Amino Acid Formulations.
Kissi EO; Kasten G; Löbmann K; Rades T; Grohganz H
Mol Pharm; 2018 Sep; 15(9):4247-4256. PubMed ID: 30020794
[TBL] [Abstract][Full Text] [Related]
28. Improvement in Inhalation Properties of Theophylline and Levofloxacin by Co-Amorphization and Enhancement in Its Stability by Addition of Amino Acid as a Third Component.
Ueda H; Hirakawa Y; Miyano T; Nakayama Y; Hatanaka Y; Uchiyama H; Tozuka Y; Kadota K
Mol Pharm; 2023 Dec; 20(12):6368-6379. PubMed ID: 37942959
[TBL] [Abstract][Full Text] [Related]
29. A Multivariate Approach for the Determination of the Optimal Mixing Ratio of the Non-Strong Interacting Co-Amorphous System Carvedilol-Tryptophan.
Di R; Liu J; Grohganz H; Rades T
Molecules; 2021 Feb; 26(4):. PubMed ID: 33557164
[TBL] [Abstract][Full Text] [Related]
30. Properties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage.
Sovago I; Wang W; Qiu D; Raijada D; Rantanen J; Grohganz H; Rades T; Bond AD; Löbmann K
Molecules; 2016 Apr; 21(4):509. PubMed ID: 27104502
[TBL] [Abstract][Full Text] [Related]
31. Effects of polymer addition on the non-strongly interacting binary co-amorphous system carvedilol-tryptophan.
Wang Y; Grohganz H; Rades T
Int J Pharm; 2022 Apr; 617():121625. PubMed ID: 35259442
[TBL] [Abstract][Full Text] [Related]
32. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
33. Functionalised calcium carbonate as a coformer to stabilize amorphous drugs by mechanochemical activation.
Liu J; Rades T; Tho I; Kissi EO
Eur J Pharm Biopharm; 2020 Oct; 155():22-28. PubMed ID: 32768607
[TBL] [Abstract][Full Text] [Related]
34. Influence of PVP molecular weight on the microwave assisted in situ amorphization of indomethacin.
Doreth M; Löbmann K; Priemel P; Grohganz H; Taylor R; Holm R; Lopez de Diego H; Rades T
Eur J Pharm Biopharm; 2018 Jan; 122():62-69. PubMed ID: 28986296
[TBL] [Abstract][Full Text] [Related]
35. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
Int J Pharm; 2007 May; 336(1):22-34. PubMed ID: 17174493
[TBL] [Abstract][Full Text] [Related]
36. Transformations between Co-Amorphous and Co-Crystal Systems and Their Influence on the Formation and Physical Stability of Co-Amorphous Systems.
Wu W; Wang Y; Löbmann K; Grohganz H; Rades T
Mol Pharm; 2019 Mar; 16(3):1294-1304. PubMed ID: 30624075
[TBL] [Abstract][Full Text] [Related]
37. Preparation and recrystallization behavior of spray-dried co-amorphous naproxen-indomethacin.
Beyer A; Radi L; Grohganz H; Löbmann K; Rades T; Leopold CS
Eur J Pharm Biopharm; 2016 Jul; 104():72-81. PubMed ID: 27130786
[TBL] [Abstract][Full Text] [Related]
38. Screening for differences in the amorphous state of indomethacin using multivariate visualization.
Savolainen M; Heinz A; Strachan C; Gordon KC; Yliruusi J; Rades T; Sandler N
Eur J Pharm Sci; 2007 Feb; 30(2):113-23. PubMed ID: 17169536
[TBL] [Abstract][Full Text] [Related]
39. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
Lu W; Rades T; Rantanen J; Yang M
Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
[TBL] [Abstract][Full Text] [Related]
40. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
